Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treat... Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treatment of patients with COVID-19 in the hospital and community settings, the treatment of patients with chronic hepatitis C infection, the treatment of patients with dengue, and the treatment of high-risk patients with severe respiratory syncytial virus infection. The company's medicinal chemistry, virology, and pharmacology expertise, bolstered by its collective experience in drug development, enables it to pioneer new advancements in antiviral science. Show more
97% SVR12 Rate Observed with 8 Weeks of Treatment in Lead-In Cohort of HCV-Infected Patients in Ongoing Phase 2 Clinical Study EASL Presentations Continue to Support Best-in-Class Potential with...
BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral...
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -4.69208211144 | 3.41 | 3.41 | 3.205 | 334995 | 3.30411081 | CS |
4 | -0.5 | -13.3333333333 | 3.75 | 3.97 | 3.205 | 309498 | 3.52040094 | CS |
12 | -0.57 | -14.9214659686 | 3.82 | 4.1399 | 3.205 | 264040 | 3.67195727 | CS |
26 | 0.18 | 5.86319218241 | 3.07 | 4.6 | 3.01 | 368026 | 3.85267412 | CS |
52 | -0.43 | -11.6847826087 | 3.68 | 4.6 | 2.765 | 368299 | 3.51183405 | CS |
156 | -20.05 | -86.0515021459 | 23.3 | 46.9099 | 2.765 | 980676 | 12.43829043 | CS |
260 | -26.69 | -89.1449565798 | 29.94 | 94.1737 | 2.765 | 933889 | 15.38588028 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.